Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             58 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Alcoholism worsens the survival of patients with hepatitis B virus and C virus-related hepatocellular carcinoma Lee, Yun-Hsuan
2012
7 2 p. 645-654
artikel
2 Amelioration of hepatic inflammation in a mouse model of NASH using a dithiocarbamate derivative Schwartz, Jason J.
2013
7 2 p. 600-609
artikel
3 Are physicians following guidelines? A survey of Hepatitis B management strategies Lee, Keat Hong
2012
7 2 p. 451-459
artikel
4 Autoimmune acute liver failure: an emerging etiology for intractable acute liver failure Fujiwara, Keiichi
2012
7 2 p. 335-346
artikel
5 B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease Miyake, Teruki
2012
7 2 p. 539-547
artikel
6 Cell-free DNA as a potential marker to predict carbon tetrachloride-induced acute liver injury in rats Gruenbaum, Benjamin Fredrick
2012
7 2 p. 721-727
artikel
7 Changing etiology of liver failure in 3,916 patients from northern China: a 10-year survey You, Shaoli
2013
7 2 p. 714-720
artikel
8 Clinicopathologic study on complications of orthotopic liver transplantation in 54 patients with chronic hepatitis B viral infection Pei, Fei
2013
7 2 p. 468-476
artikel
9 Combination and evolution of HBV mutant strains in the HBeAg-positive status predict clinical outcomes after HBeAg seroconversion Chen, Chien-Hung
2012
7 2 p. 477-488
artikel
10 Combining the HBsAg decline and HBV DNA levels predicts clinical outcomes in patients with spontaneous HBeAg seroconversion Yang, Shih-Cheng
2012
7 2 p. 489-499
artikel
11 Current management and recommendations on hepatitis B therapy in HIV-coinfected patients Piroth, Lionel
2011
7 2 p. 437-442
artikel
12 Differences in the factors associated with serum viral load between genotypes 1 and 2 in patients with chronic hepatitis C Sato, Shunsuke
2011
7 2 p. 508-515
artikel
13 Diffusion-weighted imaging of hepatocellular carcinoma for predicting early recurrence and survival after hepatectomy Muhi, Ali
2012
7 2 p. 662-668
artikel
14 Entecavir improves the outcome of acute-on-chronic liver failure due to the acute exacerbation of chronic hepatitis B Lin, Bingliang
2013
7 2 p. 460-467
artikel
15 Ethnicity predicts metabolic syndrome after liver transplant Couto, Claudia A.
2012
7 2 p. 741-748
artikel
16 Fatty liver score and 15-year incidence of type 2 diabetes Kotronen, Anna
2013
7 2 p. 610-621
artikel
17 Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients Piratvisuth, Teerha
2011
7 2 p. 429-436
artikel
18 Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype Li, Wenpeng
2012
7 2 p. 443-450
artikel
19 Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management Liu, Chun-Jen
2011
7 2 p. 316-326
artikel
20 High alanine aminotransferase level as a predictor for the incidence of macrovascular disease in type 2 diabetic patients with fatty liver disease Inoue, Megumi
2012
7 2 p. 555-561
artikel
21 Human-induced pluripotent stem cells as a source of hepatocyte-like cells: new kids on the block Busletta, C.
2011
7 2 p. 299-305
artikel
22 Humoral autoimmune response heterogeneity in the spectrum of primary biliary cirrhosis Dellavance, Alessandra
2012
7 2 p. 775-784
artikel
23 Humoral autoimmune response heterogeneity in the spectrum of primary biliary cirrhosis Dellavance, Alessandra

7 2 p. 775-784
artikel
24 IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection Abdo, Ayman A.
2013
7 2 p. 533-538
artikel
25 Impact of combined therapy with alpha-lipoic and ursodeoxycolic acid on nonalcoholic fatty liver disease: double-blind, randomized clinical trial of efficacy and safety Gianturco, Vincenzo
2012
7 2 p. 570-576
artikel
26 Inhibition of silent information regulator 1 induces glucose metabolism disorders of hepatocytes and enhances hepatitis C virus replication Yu, Jian-Wu
2013
7 2 p. 524-532
artikel
27 Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma Ogasawara, Sadahisa

7 2 p. 703-713
artikel
28 Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma Ogasawara, Sadahisa
2013
7 2 p. 703-713
artikel
29 Insulin resistance, inflammation, and nonalcoholic fatty liver disease in non-obese adults without metabolic syndrome components Kim, Seonah
2012
7 2 p. 586-591
artikel
30 Is transarterial chemoembolization beneficial for patients with diffuse infiltrative hepatocellular carcinoma? Hung, Tsung-Hsing
2012
7 2 p. 676-682
artikel
31 Magnitude of contrast-enhanced ultrasonography as a noninvasive predictor for hepatic fibrosis: comparison with liver stiffness measurement and serum-based models Tawada, Akinobu
2012
7 2 p. 749-757
artikel
32 Maturation defective myeloid dendritic cells in nonalcoholic fatty liver disease patients release inflammatory cytokines in response to endotoxin Rana, Deepa
2012
7 2 p. 562-569
artikel
33 MELD—good for many, not as good for others … at least for now Schiano, Thomas
2012
7 2 p. 306-308
artikel
34 Model for End-Stage Liver Disease and liver cirrhosis-related complications Bertot, Luis Calzadilla
2012
7 2 p. 347-355
artikel
35 Nitric oxide and prostaglandin as mediators in the pathogenesis of hyperkinetic circulatory state in a model of endotoxemia-induced portal hypertension Rizvi, Moattar Raza
2012
7 2 p. 622-635
artikel
36 Nonalcoholic fatty liver disease following liver transplantation Satapathy, Sanjaya Kumar
2013
7 2 p. 400-412
artikel
37 Noncirrhotic portal fibrosis: a rare cause of end-stage liver disease requiring liver transplantation Taneja, Sunil
2011
7 2 p. 313-315
artikel
38 Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B Chen, Yong-Peng
2013
7 2 p. 356-368
artikel
39 Optimal preservation of liver biopsy samples for downstream translational applications Sherker, Alana R.
2013
7 2 p. 758-766
artikel
40 Oxidative stress is closely associated with insulin resistance in genotypes 1 and 3 chronic hepatitis C Hashemi, Said M.
2012
7 2 p. 516-523
artikel
41 p53 codon 72 polymorphism and hepatocellular carcinoma: a meta-analysis Jia, Shuting
2012
7 2 p. 669-675
artikel
42 Percutaneous transhepatic variceal embolization with cyanoacrylate vs. transjugular intrahepatic portal systematic shunt for esophageal variceal bleeding Tian, Xiangguo
2013
7 2 p. 636-644
artikel
43 Population-attributable estimates for risk factors associated with hepatitis B and C: policy implications for Pakistan and other South Asian countries Ahmed, Bilal
2013
7 2 p. 500-507
artikel
44 Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia Goh, Seok-Chin
2012
7 2 p. 548-554
artikel
45 Probiotics promote rapid-turnover protein production by restoring gut flora in patients with alcoholic liver cirrhosis Koga, Hironori
2012
7 2 p. 767-774
artikel
46 Remnant left liver size and recovery of living right liver donors Fong, Yuen Ki
2012
7 2 p. 734-740
artikel
47 Role of anticoagulant therapy in liver disease Plompen, Elisabeth P. C.
2013
7 2 p. 369-376
artikel
48 Short- and long-term outcomes of third liver transplantation at single centre Kamei, Hideya
2012
7 2 p. 728-733
artikel
49 Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival? Finelli, Carmine
2012
7 2 p. 413-428
artikel
50 SNPs in the promoter region of the osteopontin gene as a possible host factor for sex difference in hepatocellular carcinoma development in patients with HCV Hamaoka, Kazuhiro
2012
7 2 p. 683-692
artikel
51 Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection Seto, Wai-Kay
2011
7 2 p. 327-334
artikel
52 The BAFFling problem of B cell-activating factor in nonalcoholic fatty liver disease Puri, Puneet
2013
7 2 p. 309-312
artikel
53 The expression of transporter OATP2/OATP8 decreases in undetectable hepatocellular carcinoma by Gd-EOB-MRI in the explanted cirrhotic liver Hidaka, Masaaki
2012
7 2 p. 655-661
artikel
54 The Fatty Liver Index has limited utility for the detection and quantification of hepatic steatosis in obese patients Borman, Meredith A.
2012
7 2 p. 592-599
artikel
55 The HepaRG cell line: a valuable in vitro tool for hepatitis virus infection studies Ceelen, Liesbeth
2013
7 2 p. 394-399
artikel
56 The influence of pioglitazone on the plasma amino acid profile in patients with nonalcoholic steatohepatitis (NASH) Kakazu, Eiji
2012
7 2 p. 577-585
artikel
57 The risk factors and diagnosis of cholangiocarcinoma Wadsworth, Christopher A.
2012
7 2 p. 377-393
artikel
58 Type 2 diabetes, smoking, insulin use, and mortality from hepatocellular carcinoma: a 12-year follow-up of a national cohort in Taiwan Tseng, Chin-Hsiao
2012
7 2 p. 693-702
artikel
                             58 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland